Caryn McDowellSenior Vice President, General Counsel & Corporate Secretary
Daring to Make a Difference by shepherding our legal and corporate affairs
Caryn McDowell joined Revance as SVP, General Counsel & Corporate Secretary in May of 2018. In her current role, Ms. McDowell leads the organization’s legal strategy and operations, corporate affairs, and government affairs. Prior to Revance, Ms. McDowell served as General Counsel, Chief Compliance Officer, and Secretary at Cytokinetics, Inc., where she was instrumental in defining policies and practices for FDA/EMA product approval and commercialization, managing key alliances, and financing transactions. Previously, she was Vice President, Deputy General Counsel, and Assistant Secretary at InterMune, Inc., where she helped prepare for the U.S. approval and launch of Esbriet® (pirfenidone) and played a leadership role in InterMune’s acquisition by Roche. Earlier in her career, Ms. McDowell served in legal roles of increasing responsibility at Onyx Pharmaceuticals, Genentech, and Millennium Pharmaceuticals. Prior, she served as Senior Counsel at the Office of the Inspector General (OIG) U.S. Department of Health and Human Services and as Assistant Attorney, General Medicaid Fraud Control Unit of the Commonwealth of Massachusetts. Ms. McDowell holds a J.D. degree from Boston University School of Law, and a Bachelor of Arts in both Political Science and Judaic Studies from the University of Michigan.